The Epidemiologic Study of Human Papillomavirus Infection and Related Diseases
NCT02188004 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4691
Last updated 2019-05-07
Summary
primary purpose:Evaluate the prevalence and incidence of HPV infection and related diseases in subjects.
Secondary purpose:Analyze risk factors of HPV infection and related diseases.
Conditions
- Human Papillomavirus Infection
- Genital Warts
Sponsors & Collaborators
-
Liuzhou center of disease prevention and control
collaborator UNKNOWN -
Jun Zhang
lead OTHER
Principal Investigators
-
Jun Zhang · Xiamen University
-
Ming-Qiang Li · Liuzhou center of disease prevention and control
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-06-30
- Primary Completion
- 2016-05-31
- Completion
- 2016-05-31
Countries
- China
Study Locations
More Related Trials
-
A Phase I Clinical Trial to Evaluate the Safety of 15-valent HPV Vaccine in Healthy Chinese People Aged 18-45 Years
NCT06454175 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine
NCT02710851 ·Status: UNKNOWN ·Phase: PHASE2
-
A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males
NCT06465914 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Study of Oral Papillomavirus In Teens and Twenties
NCT00994019 ·Status: COMPLETED
-
Human Papillomavirus (HPV) Genotypes in Genital Warts in Colombian Population
NCT00847340 ·Status: COMPLETED
-
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
NCT06741150 ·Status: RECRUITING ·Phase: NA
-
Natural History of Human Papillomavirus (HPV) Infections in Mid-Adult Women (WHIM)
NCT01295242 ·Status: COMPLETED
-
Study of Treatment for HPV16+ ASC-US or LSIL
NCT03913117 ·Status: RECRUITING ·Phase: PHASE1
-
High and Low Resource Interventions to Promote HPV Vaccines
NCT03824093 ·Status: COMPLETED ·Phase: NA
-
Study of TI-0093 Injection With Recurrent/Metastatic HPV-16 Positive Solid Tumors
NCT07081984 ·Status: RECRUITING ·Phase: PHASE1
-
Effectiveness Study of Human Papilloma Virus (HPV) Vaccines to Prevent Recurrence of Genital Warts
NCT02750202 ·Status: COMPLETED ·Phase: PHASE3
-
Investigation Into the Infectivity Levels of Human Papilloma Virus (HPV) in Tonsillar Tissue
NCT02841631 ·Status: UNKNOWN
-
Evaluation of AHCC® for the Clearance of High Risk-HPV Infections in Chinese Female
NCT04633330 ·Status: RECRUITING ·Phase: NA
-
Merck IIT: RRP Pembro and Lenvatinib
NCT04645602 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Yallaferon in Chinese Population
NCT02593968 ·Status: UNKNOWN ·Phase: PHASE2
-
NWRD08 DNA Plasmid for HPV-16 and/or HPV-18 Related Cervical HSIL
NCT06276101 ·Status: RECRUITING ·Phase: PHASE1
-
Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.
NCT06705322 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Impact of a Mock-up Fact-checking Extension on HPV Vaccine Misinformation: A Survey Experiment
NCT06405048 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Promoting HPV Vaccine Through Twitter
NCT04023955 ·Status: COMPLETED
-
HPV and Male Homosexuality in General Practice?
NCT05078554 ·Status: COMPLETED
-
Human Papillomatosis Genotyping of Children in Thailand
NCT01304966 ·Status: COMPLETED
-
"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
NCT06587243 ·Status: RECRUITING ·Phase: NA
-
Multilevel Interventions to Enhance Provider Recommendations for HPV Vaccination
NCT03501992 ·Status: COMPLETED ·Phase: NA
-
Prevalence of HPV-associated Eye Infection and Cytokine Levels in Tears From Patients Diagnosed With Pterygium
NCT04117386 ·Status: COMPLETED
-
The Efficacy of Intra-lesional Bleomycin Versus Intra-lesional Purified Protein Derivative in Treatment of Palmoplantar Warts
NCT03477448 ·Status: UNKNOWN ·Phase: PHASE4